Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Boutou, P. Siakka, T. Sfetsios, G. Pitsiou, I. Trigonis, E. Serasli, N. Chavouzis, P. Boura, P. Argyropoulou, I. Stanopoulos (Thessaloniki, Greece). Pulmonary function testing parameters and exercise capacity in subjects with scleroderma. Eur Respir J 2008; 32: Suppl. 52, 1882

Member's Comments

No comment yet.

Related content which might interest you: Reduced exercise capacity and impaired pulmonary function in patients with scleroderma Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease Year: 2010 Ventilatory efficiency and exercise capacity during exercise in the patients with idiopathic pulmonary fibros Source: International Congress 2014 – Alterations of exercise and lung function in different diseases Year: 2014 Pulmonary fuction and exercise capacity evaluation in adult thalassemic patients Source: Eur Respir J 2006; 28: Suppl. 50, 708s Year: 2006 Relationship between pulmonary function tests and exercise performance in patients with alveolar proteinosis Source: Annual Congress 2013 –Clinical respiratory physiology in different diseases Year: 2013 Pulmonary rehabilitation in patients with pulmonary sarcoidosis: impact on exercise capacity and fatigue. Source: Virtual Congress 2020 – Aspects of pulmonary rehabilitation: part 1 Year: 2020 Pulmonary function and cardiopulmonary exercise tests in patients with bronchiectasis Source: Annual Congress 2010 - Exercise in healthy and non-respiratory diseases Year: 2010 The relationship between peak exercise capacity and pulmonary function in patienst with metabolic syndrome Source: International Congress 2014 – Physiotherapy assessment and techniques in respiratory and non-respiratory conditions Year: 2014 Comparison of three walking tests to cardiopulmonary exercise tests in the assessment of exercise tolerance in individuals with pulmonary arterial hypertension Source: International Congress 2016 – Physiotherapy interventions and assessment options in hospitalised patients Year: 2016 Spiroveloergometry and 6-minute walking test for exercise capacity assessment in patients with primary pulmonary hypertension Source: Eur Respir J 2005; 26: Suppl. 49, 16s Year: 2005 Gas exchange impairment under incremental exercise in sarcoidosis patients with normal resting pulmonary functions Source: Annual Congress 2008 - Pulmonary mechanics and gas exchange Year: 2008 Evaluation of hyperinflation parameters and exercise performance at maximal exercise in patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 63s Year: 2005 Predicting exercise endurance in COPD patients by lung function testing Source: Annual Congress 2010 - Exercise in respiratory diseases and oxygen therapy Year: 2010 Endurance time is the most sensitive exercise measurement for evaluating pulmonary rehabilitation efficacy in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2012 - The latest insights in pulmonary rehabilitation Year: 2012 Relationship between resting pulmonary function and exercise capacity in patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 215s Year: 2004 Influence of critical hyperinflation in exercise capacity improvement after pulmonary rehabilitation in severely obstructed patients Source: International Congress 2016 – Best abstracts in exercise capacity and testing in chronic lung diseases Year: 2016 Six-minute walk test: Comparison with cardiopulmonary exercise test performance, lung function and arterial blood gases in patients with bronchiectasis Source: Annual Congress 2011 - Clinical parameters in airway diseases Year: 2011 Evaluation of exercise capacity and mechanisms of limitation during cardiopulmonary exercise testing (CPET) in patients with chronic hypersensitivity pneumonitis Source: International Congress 2018 – New methods and concepts in exercise testing Year: 2018 Maximal cardiopulmonary exercise testing in mildly symptomatic patients with idiopathic pulmonary arterial hypertension: correlations with 6-min walk distance and resting hemodynamics Source: Annual Congress 2009 - Pulmonary vascular diseases Year: 2009 Exercise capacity in chronic obstructive pulmonary disease: Cardiopulmonary exercise testing versus 6-minute walk test Source: International Congress 2019 – Clinical implications of COPD management Year: 2019 Cardiopulmonary exercise test unveils abnormal exercise physiology in patients affected by pulmonary arterial hypertension with a low-risk profile 6 minute walk distance. Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension Year: 2020